Clinical trial
Impact of Analgesia on Cancer Recurrence and Mortality Within Five Years After Stage I Non-Small Cell Lung Cancer Resection
NCT04656769 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Analgesia on Cancer Recurrence and Mortality Within Five Years After Stage I Non-Small Cell Lung Cancer Resection
- Lead sponsor
- University of Turin, Italy
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 17, 2018
- Completion date
- November 30, 2020
- Enrollment
- 382 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, opioid use, unspecified, recurrence tumor, thoracic surgery